Patents by Inventor David E. Hill

David E. Hill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11873695
    Abstract: An annular elastomeric packer for a blowout preventer includes a plurality of circumferentially spaced inserts, wherein at least one of the plurality of inserts includes a rib, and a foot pivotally coupled to the rib, and an elastomeric body coupled to the plurality of inserts and including an inner surface, wherein the foot is configured to resist deformation of the elastomeric body in response to the blowout preventer actuating from a first position to a second position.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: January 16, 2024
    Assignee: National Oilwell Varco, L.P.
    Inventors: Lydia Mireles, Cesar J. Gonzalez, David E. Hill, Nathan Follett, Vaishali Bhuvela, Ali Al-Quraishi
  • Publication number: 20210207450
    Abstract: An annular elastomeric packer for a blowout preventer includes a plurality of circumferentially spaced inserts, wherein at least one of the plurality of inserts includes a rib, and a foot pivotally coupled to the rib, and an elastomeric body coupled to the plurality of inserts and including an inner surface, wherein the foot is configured to resist deformation of the elastomeric body in response to the blowout preventer actuating from a first position to a second position.
    Type: Application
    Filed: May 29, 2019
    Publication date: July 8, 2021
    Applicant: National Oilwell Varco, L.P.
    Inventors: Lydia Mireles, Cesar J. Gonzalez, David E. Hill, Nathan Follett, Vaishali Bhuvela, Ali Al-Quraishi
  • Patent number: 9874565
    Abstract: The present invention provides methods of treating cancer by inhibiting MECP2 and identifying cancers that will respond to therapy using MECP2 as a biomarker.
    Type: Grant
    Filed: June 23, 2014
    Date of Patent: January 23, 2018
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Daniel P. Silver, Manish Neupane, David E. Hill
  • Publication number: 20160139127
    Abstract: The present invention provides methods of treating cancer by inhibiting MECP2 and identifying cancers that will respond to therapy using MECP2 as a biomarker.
    Type: Application
    Filed: June 23, 2014
    Publication date: May 19, 2016
    Inventors: Daniel P. Silver, Manish Neupane, David E. Hill
  • Patent number: 8178317
    Abstract: Provided herein are nucleic acids, proteins, vectors, cells, kits, devices and methods useful for identifying regulatable proteins that are able to complement components of cellular signaling pathways. Also provided are compositions and methods using these complementing genes directly as markers for cancer diagnosis or prognosis and as targets for anti-neoplastic therapeutics. Further provided are methods for using changes caused by expression of the complementing genes to indirectly identify associated genes to be used as markers for cancer diagnosis or prognosis and as targets for anti-neoplastic therapeutics.
    Type: Grant
    Filed: May 1, 2008
    Date of Patent: May 15, 2012
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Thomas M. Roberts, Jean Zhao, David E. Hill, William C. Hahn, Jesse Boehm
  • Patent number: 7591979
    Abstract: An automatic, self-contained device for detecting toxic agents in a water supply includes an analyzer for detecting at least one toxic agent in a water sample, introducing means for introducing a water sample into the analyzer and discharging the water sample from the analyzer, holding means for holding a water sample for a pre-selected period of time before the water sample is introduced into the analyzer, and an electronics package that analyzes raw data from the analyzer and emits a signal indicating the presence of at least one toxic agent in the water sample.
    Type: Grant
    Filed: October 20, 2003
    Date of Patent: September 22, 2009
    Assignee: UT-Battelle, LLC
    Inventors: David E. Hill, Miguel Rodriquez, Jr., Elias Greenbaum
  • Publication number: 20090047675
    Abstract: Provided herein are nucleic acids, proteins, vectors, cells, kits, devices and methods useful for identifying regulatable proteins that are able to complement components of cellular signaling pathways. Also provided are compositions and methods using these complementing genes directly as markers for cancer diagnosis or prognosis and as targets for anti-neoplastic therapeutics. Further provided are methods for using changes caused by expression of the complementing genes to indirectly identify associated genes to be used as markers for cancer diagnosis or prognosis and as targets for anti-neoplastic therapeutics.
    Type: Application
    Filed: May 1, 2008
    Publication date: February 19, 2009
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Thomas M. Roberts, Jean Zhao, David E. Hill, William C. Hahn, Jesse Boehm
  • Publication number: 20080305490
    Abstract: A human gene has been discovered which is genetically altered in human tumor cells. The genetic alteration is gene amplification and leads to a corresponding increase in gene products. Detecting that the gene, designated hMDM2, has become amplified or detecting increased expression of gene products is diagnostic of tumorigenesis. Human MD2 protein binds to human p53 and allows the cell to escape from p53-regulated growth.
    Type: Application
    Filed: July 1, 2008
    Publication date: December 11, 2008
    Applicant: The Johns Hopkins University
    Inventors: Marilee Burrell, David E. Hill, Kenneth W. Kinzler, Bert Vogelstein
  • Patent number: 7258836
    Abstract: A freeze resistant buoy system includes a tail-tube buoy having a thermally insulated section disposed predominantly above a waterline, and a thermo-siphon disposed predominantly below the waterline.
    Type: Grant
    Filed: October 20, 2003
    Date of Patent: August 21, 2007
    Assignee: UT-Battelle, LLC
    Inventors: David E. Hill, Miguel Rodriguez, Jr., Elias Greenbaum, James W. Klett
  • Patent number: 7181961
    Abstract: A precipitation gauge including a clear elongated outer cylinder and an opaque or translucent inner member disposed longitudinally in the outer cylinder to define a tubular water receiver in the space between the cylinder and the inner member and markings disposed along either the outer cylinder or the inner member, the gauge indicating the amount of water collected in the water receiver with a sharp demarcation at the top surface of the water resulting from an optical illusion making it appear that the portion of the gauge below the demarcation is filled with a fluid of the color of the inner member.
    Type: Grant
    Filed: September 3, 2004
    Date of Patent: February 27, 2007
    Inventor: David E. Hill
  • Patent number: 6048701
    Abstract: Antibodies directed to human protein mismatch repair proteins can be used diagnostically to discriminate between proliferating and non-proliferating cells. In addition, they can be used to determine whether cells have a mismatch repair defect caused by a mutation in e.g., hMSH2, hMLH1, or hPMS2. They can also be used to monitor the efficacy of anti-neoplastic therapies.
    Type: Grant
    Filed: September 9, 1996
    Date of Patent: April 11, 2000
    Assignee: The Johns Hopkins University
    Inventors: Kenneth W. Kinzler, Bert Vogelstein, Marilee Burrell, David E. Hill, Fredrick S. Leach
  • Patent number: 5910418
    Abstract: Antibodies and assays employing them are taught which are useful for detecting the bulk of mutations which occur in the APC gene in familial adenomatous polyposis. The antibodies are specific for epitopes in the amino terminal or carboxy terminal portion of the protein. A variety of immunoassay formats are described which are all based on the observation that the bulk of the APC mutations which occur in familial adenomatous polyposis and sporadic colorectal carcinomas result in truncated APC proteins. Generally, either the size of APC proteins is determined or the relative binding of amino terminal-binding antibodies to carboxy terminal-binding antibodies is determined.
    Type: Grant
    Filed: January 9, 1995
    Date of Patent: June 8, 1999
    Assignee: The Johns Hopkins University
    Inventors: David E. Hill, Karen A. Johnson, Kenneth W. Kinzler, Bert Vogelstein
  • Patent number: 5858976
    Abstract: A human gene has been discovered which is genetically altered in human tumor cells. The genetic alteration is gene amplification and leads to a corresponding increase in gene products. Detecting that the gene, designated hMDM2, has become amplified or detecting increased expression of gene products is diagnostic of tumorigenesis. Human MDM2 protein binds to human p53 and allows the cell to escape from p53-regulated growth.
    Type: Grant
    Filed: February 14, 1997
    Date of Patent: January 12, 1999
    Assignee: The Johns Hopkins University
    Inventors: Marilee Burrell, David E. Hill, Kenneth W. Kinzler, Bert Vogelstein
  • Patent number: 5736338
    Abstract: In certain human tumor cells, the gene encoding MDM2 protein is amplified and expression of MDM2 protein is elevated. Since human MDM2 protein binds to human p53, excess MDM2 protein apparently releases a cell from p53-regulated growth. Detection of elevated amounts of human MDM2 protein thus can be used to diagnose neoplastic disease in a human.
    Type: Grant
    Filed: February 17, 1995
    Date of Patent: April 7, 1998
    Assignee: The Johns Hopkins University
    Inventors: Marilee Burrell, David E. Hill, Kenneth W. Kinzler, Bert Vogelstein
  • Patent number: 5708136
    Abstract: A human gene has been discovered which is genetically altered in human tumor cells. The genetic alteration is gene amplification and leads to a corresponding increase in gene products. Detecting that the gene, designated hMDM2, has become amplified or detecting increased expression of gene products is diagnostic of tumorigenesis. Human MDM2 protein binds to human p53 and allows the cell to escape from p53-regulated growth.
    Type: Grant
    Filed: February 17, 1995
    Date of Patent: January 13, 1998
    Assignee: The Johns Hopkins University
    Inventors: Marilee Burrell, David E. Hill, Kenneth W. Kinzler, Bert Vogelstein
  • Patent number: 5618921
    Abstract: A human gene has been discovered which is genetically altered in human tumor cells. The genetic alteration is gene amplification and leads to a corresponding increase in gene products. Detecting that the gene, designated hMDM2, has become amplified or detecting increased expression of gene products is diagnostic of tumorigenesis. Human MDM2 protein binds to human p53 and allows the cell to escape from p53-regulated growth. Antibodies to the human MDM2 protein and kits containing MDM2 specific antibodies are disclosed.
    Type: Grant
    Filed: February 17, 1995
    Date of Patent: April 8, 1997
    Assignee: The Johns Hopkins University
    Inventors: Marilee Burrell, David E. Hill, Kenneth W. Kinzler, Bert Vogelstein
  • Patent number: 5606044
    Abstract: A human gene has been discovered which is genetically altered in human tumor cells. The genetic alteration is gene amplification and leads to a corresponding increase in gene products. Detecting that the gene, designated hMDM2, has become amplified or detecting increased expression of gene products is diagnostic of tumorigenesis. Human MDM2 protein binds to human p53 and allows the cell to escape from p53-regulated growth.
    Type: Grant
    Filed: February 17, 1995
    Date of Patent: February 25, 1997
    Assignee: The Johns Hopkins University
    Inventors: Marilee Burrell, David E. Hill, Kenneth W. Kinzler, Bert Vogelstein
  • Patent number: 5420263
    Abstract: A human gene has been discovered which is genetically altered in human tumor cells. The genetic alteration is gene amplification and leads to a corresponding increase in gene products. Detecting that the gene, designated hMDM2, has become amplified or detecting increased expression of gene products is diagnostic of tumorigenesis. Human MDM2 protein binds to human p53 and allows the cell to escape from p53-regulated growth.
    Type: Grant
    Filed: April 7, 1993
    Date of Patent: May 30, 1995
    Assignee: The Johns Hopkins University
    Inventors: Marilee Burrell, David E. Hill, Kenneth W. Kinzler, Bert Vogelstein
  • Patent number: 5174607
    Abstract: A clipboard arrangement includes a planar base member having a raised peripheral rim and a suction cup mounting plate hingedly mounted to a top edge of the base member. A removable clipboard assembly is selectively mounted to the planar base member and has a clamp plate at its upper edge for mounting a writing pad upon the clipboard. A bottom bracket extends outwardly from the base member to cradle and hold the clipboard bottom edge and a tang and slot juncture extends between the clipboard and the planar base member toward upper portions of the clipboard and base member so that a clipboard can be easily lifted slightly upwardly and then outwardly from the base member for carrying. Use of the clipboard arrangement permits the user to semi-permanently mount the planar base member to a suitable surface within a vehicle, such as a windshield or dashboard and then to easily remove the clipboard when going about his or her business, such as shopping or running errands.
    Type: Grant
    Filed: December 4, 1991
    Date of Patent: December 29, 1992
    Inventor: David E. Hill
  • Patent number: D248879
    Type: Grant
    Filed: August 6, 1976
    Date of Patent: August 8, 1978
    Inventor: David E. Hill